- Title
- Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial
- Creators
- Leslie M. Randall (Author)Michael W. Sill (Author)Robert A. Burger (Author)Bradley J. Monk (Author) - Creighton UniversityBarbara Buening (Author)Joel I. Sorosky (Author)
- Publication Details
- Gynecologic Oncology, Vol.124(3), pp.563-568
- Number of pages
- 563-568
- Identifiers
- 991005931634202656
- Academic Unit
- School of Medicine
- Resource Type
- Journal article
Journal article
Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial
Gynecologic Oncology, Vol.124(3), pp.563-568
2012
PMID: 22138229
Metrics
5 Record Views